Intravenous ibuprofen is a non-steroidal anti-inflammatory drug (NSAID), and used in the treatment of pain, fever, and inflammation. The IV route for ibuprofen administration provide fast action as compared to the other routes, and is preferred for the management of post-operative and acute pain.
MARKET SCOPE
The "Global Intravenous Ibuprofen Professional Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Intravenous Ibuprofen Professional market with detailed market segmentation by indication, age group, and geography. The report provides key statistics on the market status of the leading Intravenous Ibuprofen Professional market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
- Based on indication, the global Intravenous Ibuprofen Professional market is segmented into pain, inflammation, fever.
- On the basis of age group, the market is segmented into pediatrics, adults.
Drivers-
- Increasing prevalanve of chronic diseases.
- Increasing number of surgeries.
- Rising investment in research and development activities.
- Side effects associated with IV ibuprofen
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The Intravenous Ibuprofen Professional market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the Intravenous Ibuprofen Professional market in these regions.
IMPACT OF COVID-19 ON INTRAVENOUS IBUPROFEN PROFESSIONAL MARKET
The global impacts of COVID-19 are being felt across several markets. Although the healthcare sector had witnessed SARS, H1N1, and other outbreaks in the last few years, the severity of the COVID-19 has made the situation more complicated due to its mode of transmission. As a result, health care systems are overburdened, and the delivery of medical care to all patients has become a challenge in the region. Also, to free-up limited space for people being treated for the virus, hospitals have postponed, or cancelled appointments of other chronic procedures. This has negatively impacted intravenous ibuprofen professional market.
MARKET PLAYERS
The report covers key developments in the Intravenous Ibuprofen Professional market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from Intravenous Ibuprofen Professional market are anticipated to lucrative growth opportunities in the future with the rising demand for Intravenous Ibuprofen Professional in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Intravenous Ibuprofen Professional market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
- Cumberland Pharmaceuticals Inc.
- Alveda Pharmaceuticals, Inc.
- CSL Limited
- Sandor Medicaids Pvt. Ltd.
- PT. Soho Industri Pharmasi
- Germin MED
- Grifols S.A.
- Harbin Gloria Pharmaceuticals Co., Ltd
- Al Nabeel International Ltd
- Laboratorios Valmorca, C.A.